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Abstract
Mitochondria are damaged by cardiac ischemia-reperfusion (I/R) injury
but can contribute to cardioprotection. We tested if hyperkalemic cardioplegia
(CP) and lidocaine (LID) differently modulate mitochondrial (m) bioenergetics
and protect hearts against I/R injury. Guinea pig hearts (n=71) were perfused
with Krebs Ringer's (KR) solution before perfusion for 1 min just before
ischemia with either CP (16 mM K+), or LID (1 mM) or KR (control, 4 mM K+).
The 1 min perfusion period assured treatment during ischemia but not on
reperfusion. Cardiac function, NADH, FAD, m[Ca2+] and superoxide (ROS)
were assessed at baseline, during the 1 min perfusion, and continuously
during I/R. During the brief perfusion before ischemia, CP and LID decreased
ROS and increased NADH without changing m[Ca2+]. Additionally, CP
decreased FAD. During ischemia, NADH was higher and ROS was lower after
CP and LID, whereas m[Ca2+] was lower only after LID. On reperfusion, NADH
and FAD were more normalized, and m[Ca2+] and ROS remained lower after
CP and LID. Better functional recovery and smaller infarct size after CP and
LID were accompanied by better mitochondrial function. These results
suggest that mitochondria may be implicated, directly or indirectly, in
protection by CP and LID against I/R injury.

Keywords: ischemia/reperfusion, lidocaine, mitochondrial calcium load,
mitochondrial redox potential, potassium cardioplegia, reactive oxygen
species

Introduction
Myocardial injury can occur during cardiac surgery,
cardiopulmonary bypass or drug-induced hypothermic circulatory
arrest. Although several primary methods of preserving myocardial
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function have been developed, these techniques are being constantly
modified and refined to achieve the most optimal post operative
outcome.1 Potassium depolarization is a fundamental component of
modern cardioplegia2 solutions and is an important adjunct to
hypothermia in that it can provide significant added protection if
ischemia occurs during cardiac surgery. However, there remains
controversy over what constitutes an optimal hyperkalemic
cardioplegia (CP) solution, insofar as hyperkalemia, per se, may
predispose the myocardium to accumulation of intracellular Na+,3 and
may cause some deleterious effects such as cytosolic Ca2+ uptake.4
During hyperkalemic arrest the Na+/K+ ATPase pump has been shown
to be active, which may compromise recovery on reperfusion.5 It was
postulated that plasma membrane hyperpolarizing agents, such as the
Na+ channel blocker lidocaine (LID) might have an advantage over
depolarizing, hyperkalemic solutions by providing a better
maintenance of cell membrane potential and ion homeostasis.6 Indeed,
several studies have shown that adding a hyperpolarizing agent to a
high K+ CP improved function and reduced cellular damage.7-10
Mitochondria play a key role in ischemia/reperfusion (I/R)induced injury. During I/R a decrease in cytosolic pH occurs because of
anaerobic metabolism; this acidity leads to increased cytosolic Na+ and
in tandem to increased cytosolic Ca2+. As a result, mitochondrial Ca2+
(mCa2+) can rise to a high level, which can lead to abrupt cell death or
eventually to opening of the mitochondrial permeability transition pore
(MPTP), which allows released cytochrome c and other factors to
trigger apoptotic cell death. Mitochondria also play a key role in
generating reactive O2 species (ROS), not only during reperfusion, but
also during ischemia; ROS contribute to mitochondrial injury and
subsequent cell damage.11-13 Therefore, targeting the mitochondrion to
alleviate I/R injury has engendered much interest in understanding the
mitochondrial component of cardioprotection. Indeed, we14-16 and
other investigators17 have shown recently that targeting mitochondrial
electron transport chain (ETC) complex I protected against I/R injury.
CP and LID, in addition to their mechanism of action to arrest
action potential and contractile activity, may also have direct or
indirect effects at the mitochondrial level. We questioned if CP or LID
would better preserve mitochondrial bioenergetics and protect against
myocardial I/R injury by a brief reduction in metabolic activity before
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ischemia (indirect effect), or by an effect on mitochondrial
bioenergetics during ischemia (direct effect). To address this we
investigated effects of both CP and LID on the mitochondrial redox
state, ROS, and mitochondrial Ca2+ (m[Ca2+]) as each variable was
measured continuously in intact beating hearts during I/R. We
hypothesized that CP or LID, given just before ischemia, would
differentially preserve mitochondrial redox state and decrease ROS
generation and m[Ca2+] during I/R. To our knowledge, this is the first
study to compare the effects of these two methods of arresting hearts
on mitochondrial function measured continuously in isolated perfused
hearts.

Materials and Methods
Langendorff Heart Preparation
The investigation conformed to the Guide for the Care and Use
of Laboratory Animals (US National Institutes of Health Publication No.
85-23, Revised 1996). The Medical College of Wisconsin Biomedical
Resources Studies Committee approved this study. Guinea pig hearts
(n=71) were isolated and prepared as previously described in detail.1823
Animals were anesthetized with ketamine (50 mg/kg) and heparin
was administered to prevent clotting. Following decapitation and
thoracotomy, hearts were removed and perfused at 55 mmHg via the
aortic root with a Krebs Ringer's solution (KR: in mM 138 Na+, 4.5 K+,
1.2 Mg2+, 2.5 Ca2+, 134 Cl-, 15 HCO3-, 1.2 H2PO4-, 11.5 glucose, 2
pyruvate, 16 mannitol, 0.1 probenecid, 0.05 EDTA, and 5 U/L insulin)
gassed with 3% CO2, 97% O2 (pH 7.4) at 37°C. Pyruvate improves
performance in guinea pig hearts,24,25 and mannitol, a non-metabolized
sugar, supports the oncotic pressure of the KR solution. Probenecid
was added to accentuate loading of fluorescent dyes.26 A saline-filled
balloon catheter attached to a transducer was used to measure LV
pressure (LVP). Coronary flow was measured using an ultrasonic
flowmeter (model T106X; Transonic Systems, Ithaca, NY) placed
directly into the aortic inflow line as previously described.18-23
Spontaneous heart rate was monitored with bipolar electrodes placed
in the right atrial and ventricular walls.27 Cardiac O2 delivery was
calculated as coronary flow • heart weight−1 • PaO2 • 24 μl O2 / ml
(37°C) at 760 mmHg, O2 consumption (MVO2) as coronary flow • heart
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weight−1 • (PaO2 – PvO2) • 24 μl O2 / ml (37°C) at 760 mmHg, and
cardiac efficiency as developed LVP • heart rate / MVO2.

Measurements of Cardiac Mitochondrial Redox State,
O2•- and [Ca2+]
All fluorescence signals were detected at 103 to 105 photons/s.
FAD fluorescence is derived only from mitochondria; the majority of
the NADH signal also arises from mitochondria28-30 The majority of
superoxide (O2•-) likely originates from cardiac mitochondria with only
small part derived from non-mitochondrial sources because O2•generation in the isolated heart is very sensitive to mitochondrial
inhibitors and insensitive to inhibitors of xanthine oxidase.19 It is also
possible that non-myocyte sources such as endothelial and other
sources can contribute to the total O2•- generated. For example, the
mitochondrial content in endothelial cells ranges between 2-5%31 while
mitochondria comprise 22-37% of the volume of cardiac myocytes.32,33
These observations lead to the conclusion that most of the O2•generated in ischemic hearts originates in mitochondria of cardiac
myocytes. Myocardial Ca2+ signals arise from noncytosolic sources
after quenching by MnCl2;34 the major noncytosolic source is the
mitochondrial compartment because of its large volume relative to cell
volume.32,33
NADH and FAD, m[Ca2+], and ROS production were measured
near continuously through the LV free wall using one of four excitation
and emission fluorescence spectra18-23 in different subsets of hearts. A
trifurcated fiberoptic probe (3.8 mm2/bundle) was placed against the
LV to excite and record light signals at specific wavelengths using
spectrophotofluorometers (SLM Instruments Inc, Urbana, IL; or Photon
Technology International, London, Ontario). Light penetration and its
fluorescence sensitivity are dependent on the light source intensity and
wavelength. For Ca2+ the signal is transmural but attenuated at the
endocardial surface to 20 to 30% of that at the epicardial surface.35
In a subset of hearts, as described previously,20,21,36 10 μM
dihydroethidium (DHE), a fluorescent probe used to detect the O2•radical,37-39 was loaded for 20 min and washed out, the LV free wall
was excited at 540 nm, and light emission was recorded at 590 nm.
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O2•- non-enzymatically converts DHE to 2-hydroxyethidium (2-OH-E+)
or a precursor that appears to be rapidly made, is labile, and
fluoresces at a slightly shorter wavelength than the heme-peroxidase
oxidation product ethidium that can intercalate to bind with DNA.38,39
In other hearts NADH autofluorescence was assessed at 350 nm
excitation and 450 and 390 nm emissions, and FAD autofluorescence
at 480 nm excitation and 540 nm emission.14,22,30,40
Alternatively, other hearts were loaded with 6 μM indo 1 AM for
30 min to measure Ca2+ transients using an excitation of 350 nm and
emissions of 390 and 450 nm. After initially observing cytosolic Ca2+
transients, hearts were perfused for 15 min with 100 μM MnCl2 to
quench the cytosolic indo 1 signal41,42 and then washed out for 15 min.
MnCl2 slightly increased LVP which returned to its original value upon
washout. The remaining fluorescent signal after quenching represented
the m[Ca2+] signal.34 To estimate actual m[Ca2+] during the entire
protocol, NADH autofluorescence was subtracted from the underlying
changes in mCa2+ fluorescent signals for each group.14,27,43 Each signal
was digitized and recorded at 200 Hz on computers for later analysis
using specifically designed computational programs and commercial
software. pH alone in the range of 6.2-8.0 does not alter the DHE
fluorescence in our model.20 Also in preliminary experiments, we found
that a decrease in pH from 7.4 to 6.5 did not significantly change the
indo 1 AM fluorescence signal, and that the effects of low pH on NADH
are negligible. This excludes the possibility of lactic acidosis buildup
during ischemia from having significant effects on mCa2+, O2•-, and
NADH signals during ischemia.

Protocol
The study had four groups: control (CON, [K+] at 4 mM, n=15);
high [K+] cardioplegia in KR solution (CP, [K+] at 16 mM, n=21);
lidocaine in KR solution (LID, 1 mM, n=20); and time control (n=15).
Each group contained subsets of hearts to independently measure and
record either NADH plus FAD, m[Ca2+], or O2•-. Each heart initially
underwent a stabilization period followed by loading and washout of
unbound dye to specifically measure either m[Ca2+] or O2•-. NADH and
FAD autofluorescence were assessed simultaneously14,27,43,44 using a
protocol similar to that of the indo 1 fluorescence dye-loaded hearts.
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All hearts undergoing ischemia were perfused for only 1 min with
either KR alone (CON), CP, or LID immediately before the onset of 30
min no flow global ischemia. This protocol assured that hearts were
treated only during the ischemic period and not during reperfusion.
This treatment effect is not a classical preconditioning protocol in
which a drug is first washed out before ischemia. In our protocol
hearts began to beat immediately on reperfusion in the CP and LID
treated hearts. This confirms that effects of CP and LID were limited to
the 1 min perfusion and during ischemia.
CP and LID did not alter the fluorescence characteristics or
spectra of any dye. Therefore, any observed changes in fluorescent
spectra were most likely attributed only to the effects induced by I/R.
After ischemia each heart was reperfused with KR solution for 120 min
without additional treatment. At the end of each experiment hearts
were removed and atria were discarded; ventricles were cut into thin
transverse sections (4-5) of approximately 3 mm each and incubated
in buffered 0.1% 2,3,5-triphenyltetrazolium chloride (TTC) to stain
viable tissue from necrotic tissue for estimating infarct size.

Statistical Analysis
Measurements for each group were compared at baseline,
during the 1 min treatment before ischemia, at 15 and 30 min
ischemia, and at 5, 30, 60, and 120 min reperfusion. All data are
expressed as mean ± SEM. Values for NADH, FAD and O2•- are
expressed in arbitrary fluorescence units (afu) with the times factors
for photon units/s removed, and m[Ca2+] is given in nM. Between
groups and within group comparisons were done by two-way analysis
of variance to determine significance. If F values were significant (P <
0.05), post hoc comparisons of means tests (Student-Newman-Keuls)
were used to compare the three groups within each subset.
Differences between means were considered significant when P < 0.05
(two-tailed).

Results
Baseline values were not different among groups for all
measurements. To assess the role of mitochondria in the overall
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cardiac functional and metabolic recovery afforded by CP and LID,
mitochondrial function, i.e., NADH plus FAD, O2•- production, and
m[Ca2+] were monitored in different subsets of hearts undergoing the
same protocol described earlier. Figures 1(a) and 2(a) show
respectively timeline changes in NADH (baseline value 55±0.2 afu)
and FAD (baseline value 61±0.7 afu) (indicators of mitochondrial
redox state) before, during, and after ischemia. An increase in NADH
and a decrease in FAD indicate a more reduced mitochondrial state,
while a decrease in NADH and an increase in FAD indicate a more
oxidized state.14,43 Ischemia initially caused an increase in NADH
autofluorescence (afu) (62±1 afu) and a decrease in FAD (58±1 afu)
autofluorescence in each group indicating a more reduced redox state
during the onset of ischemia. During late ischemia mitochondria
became less reduced as shown by the decline in NADH (56±3 afu) in
the CON group. The CP and LID groups did not show a decline in NADH
as did the CON group during ischemia (64±2, 65±3 afu, respectively).
By 60 min reperfusion mitochondrial redox state (NADH and FAD)
returned to baseline in CP and LID treated hearts (NADH: 52±1, 53±1,
FAD: 61±1, 63±1 afu, respectively) but was markedly compromised in
the CON group, as exemplified by the increase in FAD (67±3 afu) and
decrease in NADH (46±1 afu) above and below baseline, respectively.
This indicates that mitochondrial redox potential was better preserved
with CP and LID treatment, while mitochondria exhibited a more
oxidized state in the CON group.
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Figure 1. (a). Change in NADH autofluorescence before, during, and after 30 min
no flow, global ischemia for CON (n=5), CP (n=8), and LID (n=5) groups. Time control
experiments (n=5) without concomitant ischemia are also shown. Arrow indicates 1
min CP or LID perfusion immediately before ischemia. Figure 1(b). Effect of CP or LID
perfusion before ischemia on NADH; white and hatched bars represent baseline and 1
min of treatment. #P < 0.05, 1 min perfusion before ischemia, during ischemia and
reperfusion vs. baseline values; *P < 0.05 CP or LID vs. CON; †P < 0.05 LID vs. CP
(non significant, ns).
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Figure 2. (a). Changes in FAD autofluorescence before, during, and after 30 min no
flow, global ischemia for CON (n=5), CP (n=8), and LID (n=5) groups. Time control
experiments (n=5) without concomitant ischemia are also shown. Arrow indicates 1
min CP or LID perfusion immediately before ischemia. Figure 2(b). Effect of CP or LID
perfusion before ischemia on FAD; white and hatched bars represent baseline and 1
min of treatment. #P < 0.05, 1 min perfusion before ischemia, during ischemia and
reperfusion vs. baseline values; *P < 0.05 CP or LID vs. CON; †P < 0.05 LID vs. CP
(ns).
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To evaluate the direct or indirect impact on mitochondrial redox
state by CP and LID, NADH and FAD were monitored during the 1 min
perfusion of each treatment before ischemia as shown in Figures 1(b)
and 2(b). The baseline values were not significantly different among
groups (average basal NADH: 55±0.2 afu) and FAD (average basal
FAD: 61±0.7 afu). One min of CP or LID perfusion just before ischemia
increased NADH (57.5±1.1 and 56.7±0.6 afu respectively); 1 min CP
perfusion before ischemia slightly decreased FAD (60.1±0.4 afu); LID
caused no change in FAD.
Whereas NADH and FAD are markers of the mitochondrial redox
state during I/R injury, O2•- production and m[Ca2+] are key effectors
in the mechanism of cellular injury following I/R. Figure 3(a) shows
that the O2•- (average baseline value 3.31±0.02 afu) level increased in
all groups at the onset of ischemia but surged significantly higher
during late ischemia in the CON group (4.38±0.16 afu), but not in the
CP (3.95±0.11 afu) and LID (3.65±0.13 afu) groups. During the first
20 min of reperfusion O2•- production returned to baseline in CP
(3.2±0.06 afu) and LID (3.23±0.06 afu) groups, but remained
significantly elevated in the CON group (3.57±0.14 afu). m[Ca2+]
(average baseline value 153±3 nM) tended to increase less so during
early and late ischemia in the LID group (344±82 nM at 30 min
ischemia) than in the CON (569±58 nM at 30 min ischemia) and CP
(573±119 nM at 30 min ischemia) groups (Figure 4(a)). On
reperfusion, the high m[Ca2+] that occurred during ischemia was
rapidly reversed toward baseline levels in both CP (213±9 nM at 5 min
reperfusion) and LID (173±7 nM at 5 min reperfusion) groups,
whereas it remained significantly elevated above baseline in the CON
group throughout reperfusion (374±41 nM at 5 min reperfusion).
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Figure 3. (a). Changes in superoxide (O2•-) levels before, during, and after 30 min
no flow, global ischemia for CON (n=5), CP (n=6), and LID (n=6) groups. Time control
experiments (n=5) without concomitant ischemia are also shown. Arrow indicates 1
min CP or LID perfusion immediately before ischemia. Figure 3(b). Effect of CP or LID
perfusion before ischemia on O2•-; white and hatched bars represent baseline and 1
min of treatment. #P < 0.05, 1 min perfusion before ischemia, during ischemia and
reperfusion vs. baseline values; *P < 0.05 CP or LID vs. CON; †P < 0.05 LID vs. CP
(ns).
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Figure 4. (a). Changes in m[Ca2+] before, during, and after 30 min no flow, global
ischemia for CON (n=5), CP (n=6), and LID (n=7) groups. Time control experiments
(n=5) without concomitant ischemia are also shown. Arrow indicates 1 min CP or LID
perfusion immediately before ischemia. Figure 4(b). Effect of CP or LID perfusion
before ischemia on m[Ca2+]; white and hatched bars represent baseline and 1 min of
treatment. #P < 0.05, 1 min perfusion before ischemia, during ischemia and
reperfusion vs. baseline values; *P < 0.05 CP or LID vs. CON; †P < 0.05 LID vs. CP.
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Figures 3(b) and 4(b) summarize changes in O2•- production and
m[Ca2+], respectively, during the one min treatment with either CP or
LID. O2•- production decreased slightly with CP or LID treatment,
whereas m[Ca2+] did not change.
Ventricular infarct size as a percentage of total ventricular
weight (area at risk) for all subgroups after 120 min reperfusion was
significantly larger in the CON (40±2%) group than in the CP (28±3%)
and LID (23±3%) groups. Infarcted tissue was confined principally to
the LV mesomyocardium.
All hearts beat spontaneously and there were no significant
differences in heart rate among groups at baseline. Figures 6(a) and
6(b) show timeline changes in systolic minus diastolic LVP (developed
LVP) and diastolic LVP (diaLVP), respectively. Both treatments arrested
all hearts during the 1 min period of perfusion with the arrest by LID
as prompt as for CP, and on reperfusion CP and LID treated hearts
began to beat immediately. At 5 min reperfusion developed LVP was
higher and diaLVP was lower in CP and LID groups than in the CON
group. By the end of reperfusion developed LVP and diaLVP in CP and
LID groups were similar to baseline values, whereas they remained
significantly depressed and elevated below and above baseline,
respectively, in the CON group. CP and LID caused a small, nonsignificant decrease in coronary flow (Figure 7(a)) during the 1 min
perfusion before ischemia; during early reperfusion there was a
reactive flow increase that was larger in the CP and LID groups than in
the CON group. Throughout the 120 min reperfusion period coronary
flow remained higher in the two treatment groups than in the CON
group. Effects of both treatments and control on cardiac efficiency at
baseline and during reperfusion are summarized (Figure 7(b)). Cardiac
efficiency was higher after either CP or LID throughout reperfusion.
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Figure 6. Left ventricular developed pressure (systolic–diastolic LVP (a)), and
diastolic left ventricular pressure (diaLVP (b)) before, during, and after 30 min no flow,
global ischemia for CON (n= 10), CP (n=15), and LID (n=14) groups. Time control
experiments (n=10) without concomitant ischemia are also shown. Arrow indicates 1
min CP or LID perfusion immediately before ischemia. #P < 0.05, 1 min perfusion
before ischemia, during ischemia and reperfusion vs. baseline values; *P < 0.05 CP or
LID vs. CON; †P < 0.05 LID vs. CP (ns).
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Figure 7. (a). Coronary flow before, during, and after 30 min no flow, global
ischemia for CON (n=10), CP (n=15), and LID (n=14) groups. Time control
experiments (n=10) without concomitant ischemia are also shown. Arrow indicates 1
min CP or LID perfusion immediately before ischemia. Figure 7(b). Effects of CP and
LID on cardiac efficiency at selected time points during reperfusion. #P < 0.05, 1 min
perfusion before ischemia, during ischemia and reperfusion vs. baseline values; *P <
0.05 CP or LID vs. CON; †P < 0.05 LID vs. CP (ns).

Cardiac contraction, cardiac relaxation, and metabolic data for
all groups at selected times of reperfusion after ischemia were
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compared to their respective baseline values (Table 1). Baseline values
were similar in all groups. On reperfusion, each index was more
improved in the two treatment groups than in the CON group, which
was consistent with the functional data. Note that the timeline for
mitochondrial variables and cardiac functions in the time control group
remained unchanged during the duration of the protocol indicating
stability of the preparation. Thus changes observed in the I/R groups
are solely attributed to pathophysiological conditions.
Baseline

Reperfusion
5 min

Reperfusion
30 min

Reperfusion
60 min

Reperfusion
120 min

90.8±9.2#

86.7±8.2#

94.5±8.8#

O2 Delivery
Control

139.2±12.3 110.9±13.5#

CP

160.9±11.2 186.1±11.6#* 131.2±10.1#*

129.8±9.4#*

136.8±8.8#*

LID

139.5±7.0 164.3±6.6#*

121.7±8.0*

113.7±6.4#*

128.8±5.3*

58.4±5.3#

60.2±5.1#

65.4±5.0#

O2 Consumption
Control

86.8±5.4

65.7±5.5#

CP

105.1±4.7 101.5±8.3*

88.0±5.5#*

93.9±4.9*

99.5±5.9*

LID

99.8±7.4

92.5±5.9*

80.2±4.9#*

85.0±4.8#*

96.2±3.8*

Control

1944±176

531±162#

836±134#

857±112#

882±142#

CP

1742±282

1123±211#*

1253±220*

1239±193*

1235±185*

LID

1784±106

887±178#

1298±171*

1401±108*

1360±153*

Control

-1534±143 -330±80#

-660±124#

-666±118#

-711±131#

CP

-1346±173 -766±144#*

-1036±164*

-1038±142*

-1054±126*

LID

-1458±121 -680±151#*

-1130±195*

-1225±147*

-1171±191*

dLVP/dtmax

dLVP/dtmin

Table 1. Changes in O2 Delivery, O2 Consumption and cardiac contractility and
relaxation at baseline, and at selected intervals during reperfusion. Values are
mean±sem; n=8 hearts per group
O2 Delivery (mmHg•ml•O2•min-1•g-1); O2 Consumption (O2•g-1•min-1); Cardiac
contractility and relaxation (mmHg/s)
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#P

< 0.05 vs. baseline values;
< 0.05, each treatment vs. the control group;
†P < 0.05, LID vs. CP.
*P

Discussion
Cardioplegic solutions are widely used to protect hearts against
ischemic injury during revascularization or valvular procedures while
on cardiopulmonary bypass. These solutions have been exhaustively
modified and reformulated in attempts to reach full cardiac recovery
post-operatively.45 However, to achieve optimal protection it is
important to rationally understand the mechanism by which these
solutions provide protection against I/R injury. Insofar as mitochondria
are implicated in I/R injury, the effects of these solutions on
mitochondrial bioenergetics and function would provide a better
understanding of the mechanisms of cardioprotection and the potential
of a particular cardioprotective solution. Such studies could lead to a
specific targeting of the mitochondrion in an attempt to improve
clinical outcome.
In this study we compared the impact of two preemptive
approaches to cardiac protection on mitochondrial bioenergetics and
global cardiac function in an isolated heart model. These were a
plasma membrane depolarizing cardioplegia with KCl, and a
normokalemic hyperpolarizing cardioplegia with lidocaine, both applied
only during ischemia. To our knowledge, this is the first intact heart
study to show and compare effects of these treatments on dynamic
changes in mitochondrial function (NADH, FAD), O2•- generation, and
m[Ca2+] during ischemia, and on the consequent changes in global and
mitochondrial function during reperfusion. We found that either
treatment, begun just before ischemia, resulted in a more normalized
mitochondrial redox state (NADH, FAD), lower O2•- levels during I/R,
and less mCa2+ uptake during reperfusion. This protection of
mitochondria was associated with equivalent functional recovery of
hearts as seen by the higher developed LVP, lower diastolic LVP,
smaller infarct size, and higher coronary flow in the two treatment
groups.
Mitochondrial [Ca2+] was not significantly different between CP
and CON throughout ischemia, even though functional recovery was
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worst and infarct size was largest in the CON group compared to the
treatment groups. It may be that a high m[Ca2+] during reperfusion
rather than the mCa2+ uptake during ischemia is partially responsible
for the damage induced by I/R. These data suggest that
hyperpolarization with LID treatment is marginally a better approach
than depolarization with high K+ to specifically limit mCa2+ loading
during ischemia.

CP and LID improve mitochondrial redox state during
I/R
Either NADH- or FAD-linked fluorescence can be used as a
measure of mitochondrial redox state. Autofluorescence differences
may reflect differences in electron flow through the electron transport
chain (ETC).27,44,46 Ischemia caused fluorescence to increase (more
reduced state) and FAD autofluorescence to decrease (less oxidized
state) in all groups, which is attributed to a slower mitochondrial
respiration because of the ischemia –induced reduction in tissue O2
tension and O2 as an acceptor of electrons at complex IV. The redox
state approaches the more-oxidized pre-ischemia level on reperfusion
when the O2 tension rises.47 The marked and irreversible decline in
NADH during late ischemia and early reperfusion in the CON group
compared to CP and LID could be due to an increasing volume of
irreversibly oxidized mitochondria.22
It is possible that a decline in NADH autofluorescence during
late ischemia was due to lactic acidosis, which may alter intracellular
pH and consequently intra mitochondrial pH.48 However, in preliminary
isolated heart experiments, we found negligible changes in NADH
between pH 6.5 and 7.4. Moreover, the decline in NADH during early
reperfusion in the CON group could be due to opening of the MPTP and
depletion of mitochondrial NAD+49 and to greater cell death in this
group. The decrease in redox state was associated with a larger infarct
size in the CON group. This notion is supported by our previous study22
showing a significant correlation between the rate of NADH decline
throughout I/R and infarct size in individual hearts. Thus, the
maintenance of a reduced redox state during ischemia, as shown by
CP and LID, may be a prerequisite and a marker for the improved
functional and metabolic recovery we observed.
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CP and LID reduce O2•- production and mCa2+ load
during I/R
Both excessive mitochondrial ROS and Ca2+ are implicated in I/R
injury. The cause-effect relationship between excess ROS and mCa2+
loading during I/R injury remains unsettled. We found that both CP
and LID prevented the increase in O2•- observed in the CON group
during late ischemia. Despite their low O2 content during ischemia,
mitochondria are still capable of generating ROS due to the highly
reduced redox state which promotes electron donation to residual O2
to generate O2•-.50 It is noteworthy that NADH declined during late
ischemia as the ROS level increased. This suggests that the increase in
ROS production in the CON group led to mitochondrial damage and
eventually to more cell death, and thus an irreversible decline in
NADH. The increase in ROS generation during late ischemia in the CON
group could result from mCa2+ overload that leads to inhibition of
respiration;51 however, this does not explain why O2•- was lower in the
CP group despite the higher m[Ca2+] during late ischemia.
m[Ca2+] was lower during late ischemia in the LID group than in
the CON group. This may be due to inhibited cell influx and/or release
of intracellular Ca2+ by LID.52 Also LID may reduce the Na+ loading
that occurs during ischemia and consequently reduce Na+ dependent
Ca2+ loading.53 During late ischemia m[Ca2+] unexpectedly increased in
the CP group to a level that was not significantly different from CON;
but during reperfusion m[Ca2+] was significantly higher in the CON
group than in the CP and LID treated hearts. It is unclear why CP
treatment was associated with an increase in m[Ca2+] during ischemia.
It could be due to intracellular Ca2+ loading as a consequence of K+induced membrane depolarization,54 or result from activation of
Na+/Ca2+ exchange, or from leakage of Ca2+ from the sarcoplasmic
reticulum during arrest.55 Regardless of the source of increased mCa2+
during ischemia, it appears that mCa2+ loading during ischemia may
not be as detrimental to cardiac recovery as mCa2+ loading during
reperfusion. This observation is consistent with another study in which
it was shown that the most damaging Ca2+ influx occurs during
reperfusion.56
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Do these cardioplegic solutions directly modulate
mitochondrial function?
The cardioprotection afforded by CP and LID may be mediated
through different mechanisms that directly or indirectly impact on
mitochondrial function. Although the proposed mechanism for both CP
and LID for protection against I/R involves their action on the
sarcolemmal membrane to arrest the heart and reduce metabolic
activity, there is the possibility that they also modulate mitochondrial
function directly as a mechanism for protection of the cardiac myocyte.
Our study shows that perfusion of hearts with CP for only 1 min before
ischemia caused a more reduced or (less oxidized) mitochondrial state
as evidenced by the increase in NADH and a decrease in FAD. Our
finding of the change in redox state during 1 min of CP perfusion is
consistent with other studies that showed an increase in NADH/NAD+
and FADH2/FAD ratios in hearts perfused with hyperkalemic buffer.57-59
High K+ CP could also modulate mitochondrial function by targeting
mitochondrial Na+/Ca2+ exchange (mNCX), and thus stimulate Ca2+
efflux from mitochondria where excess Ca2+ can be stored in the
sarcoplasmic reticulum during subsequent reperfusion.60 This Ca2+
dynamics may account for the fast decrease in m[Ca2+] on reperfusion
to baseline levels in the CP vs. CON groups.
Unlike for high K+ CP, there are known direct effects of LID on
mitochondria.61-65 The ability of a local anesthetic to penetrate the
cellular and mitochondrial membranes depends on its lipid solubility.66
LID can penetrate the cardiac cell membranes and be taken up by
mitochondria.66 Moreover, low concentrations (up to 1 mM) of LID
have been reported to stimulate mitochondrial respiration, whereas
higher concentrations to inhibit respiration.61,65 The increase in
mitochondrial respiration is attributed to mild uncoupling due to the
electrophoretic entry of the cationic form of the amine.67 The inhibitory
effect on the other hand could be ascribed to direct inhibition of the
ETC complexes by local anesthetics.61,68 Therefore, it is possible that
the increase in NADH we observed during the 1 min perfusion of LID
could be due to a direct effect on mitochondrial electron transfer. In
this way, LID could act in part like amobarbital, which blocks electron
transfer at the rotenone site of complex I resulting in an increase in
NADH.14
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Interestingly, like amobarbital in our previous study, LID did not
alter FAD, suggesting inhibition only of complex I of the ETC. This
notion of specifically targeting mitochondrial complex I is supported by
another study, which showed LID inhibited O2 consumption with a
complex I substrate but not with a complex II substrate.69 However
unlike amobarbital,14 LID treatment attenuated basal ROS generation
(Figure 3(b)). This observation agrees with another study showing that
LID at comparable concentrations decreased ROS generated in
neutrophils.64 LID has also been reported to have a direct scavenging
effect on peroxynitrite63 and on singlet oxygen.62 Therefore, the
protective mechanisms of LID on mitochondrial function could be
attributed to either blocking electron flow to down stream complexes
(complex III), where greater ROS generation occurs during oxidative
stress,14 to scavenging of mitochondrial ROS, or to both mechanisms.
Overall it is possible that LID directly modulates mitochondrial function
and bioenergetics to protect mitochondria against I/R injury, but its
specific effects other than those related to Na+ channel function
remains to be determined.

Summary: high K+ vs. lidocaine against IR injury
Our study demonstrates that both high K+ cardioplegia and
lidocaine, when present during global cardiac ischemia but not
reperfusion, help to preserve mitochondrial bioenergetics, reduce
mCa2+ loading during reperfusion, and reduce ROS generation during
both ischemia and reperfusion. The small but relevant changes in
mitochondrial energetics during 1 min perfusion of either of these
treatments before ischemia suggest that a mitochondrial related
mechanism could be in part responsible for the cardioprotection
conferred by these cardioplegic solutions. Although there is a definite
advantage in the use of a high K+ cardioplegic solution for
cardioprotection, there are some disadvantages, such as mCa2+
loading as shown in the present study. Moreover, it was reported that
high [K+] can decrease cardioplegic delivery in hearts with obstructed
coronary arteries9 due to K+ -induced coronary artery smooth muscle
constriction,9 whereas lidocaine may improve vasodilation and lead to
a better protection against I/R injury.70 Lidocaine may exhibit a better
preservation of ATP compared to CP. 70 In addition to the ability of
lidocaine to prevent arrhythmias, maintain ion homeostasis, and
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stabilize cellular membrane potential, lidocaine may reduce the
energy-dependent activity and thereby have energy-sparing effects.70
Our study adds to our understanding of the mechanism of a local
anesthetic vs a K+ cardioplegic solution for cardiac protection by
demonstrating the important role of mitochondrial function during I/R
injury. Although some mitochondrial differences were noted between
these treatments, we were unable to clearly ascertain if they
differentially underlied the improvements in cardiac function.

Figure 5. Infarct size as a percentage of total ventricular weight measured after
120 min reperfusion for CON (n=15), CP (n=21), and LID (n=20). *P < 0.05 CP or
LID vs. CON; †P < 0.05 LID vs. CP (ns).
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